BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25070053)

  • 1. Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study.
    Hart PA; Law RJ; Frank RD; Bamlet WR; Burch PA; Petersen GM; Rabe KG; Chari ST
    Am J Gastroenterol; 2014 Sep; 109(9):1484-92. PubMed ID: 25070053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA
    Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of pancreatic adenocarcinoma tumor staging and resection according to previous body mass index and diabetes duration.
    Souza JJ; Machado MC; Cunha JE; Jukemura J; Nery M; Wajchenberg BL; Pereira MA; Corrêa-Giannella ML; Giannella-Neto D
    Pancreatology; 2007; 7(2-3):187-93. PubMed ID: 17592233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis.
    Walter U; Kohlert T; Rahbari NN; Weitz J; Welsch T
    Ann Surg Oncol; 2014 Apr; 21(4):1082-9. PubMed ID: 24322532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
    He XY; Li JF; Yao WY; Yuan YZ
    Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer.
    Hank T; Sandini M; Qadan M; Weniger M; Ciprani D; Li A; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Pancreatology; 2020 Jan; 20(1):125-131. PubMed ID: 31706821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study.
    Balzano G; Dugnani E; Gandolfi A; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    PLoS One; 2016; 11(11):e0166008. PubMed ID: 27814399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma.
    Lee W; Yoon YS; Han HS; Cho JY; Choi Y; Jang JY; Choi H
    J Surg Oncol; 2016 Feb; 113(2):203-8. PubMed ID: 26799261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.
    He W; Zhao H; Chan W; Lopez D; Shroff RT; Giordano SH
    Surgery; 2015 Nov; 158(5):1226-34. PubMed ID: 26138347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer.
    Wu BU; Chang J; Jeon CY; Pandol SJ; Huang B; Ngor EW; Difronzo AL; Cooper RM
    Am J Gastroenterol; 2015 Aug; 110(8):1233-9. PubMed ID: 26195180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T; Hamada C; Baba H
    World J Surg; 2006 Feb; 30(2):213-8. PubMed ID: 16425074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of diabetes and perineural invasion in pancreatic cancer.
    Sahin IH; Shama MA; Tanaka M; Abbruzzese JL; Curley SA; Hassan M; Li D
    Cancer Med; 2012 Dec; 1(3):357-62. PubMed ID: 23342285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer.
    Kleeff J; Costello E; Jackson R; Halloran C; Greenhalf W; Ghaneh P; Lamb RF; Lerch MM; Mayerle J; Palmer D; Cox T; Rawcliffe CL; Strobel O; Büchler MW; Neoptolemos JP
    Br J Cancer; 2016 Sep; 115(7):887-94. PubMed ID: 27584663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis.
    Lv X; Qiao W; Leng Y; Wu L; Zhou Y
    PLoS One; 2017; 12(2):e0171370. PubMed ID: 28158300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
    Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
    JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma.
    Hamidian Jahromi A; Zibari GB; Jafarimehr E; Chu Q; Wellman GP; Shi R; Johnson LW; Shokouh-Amiri H
    Int Surg; 2014; 99(1):62-70. PubMed ID: 24444272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.